Bortezomib sensitizes thyroid cancer to BRAF inhibitor [electronic resource]
Producer: 20190104Description: 99-109 p. digitalISSN:- 1479-6821
- Animals
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Bortezomib -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Humans
- Male
- Mice, Inbred BALB C
- Mice, Nude
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Thyroid Neoplasms -- drug therapy
- Vemurafenib -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.